Cohen-Mekelburg S, et al. - The frequency of delay and risk factors associated with a delay in the initiation of prophylactic post-surgical biologic therapy in high-risk patients were identified in this analysis. A cohort study of Crohn’s disease patients who underwent a bowel resection was performed. Eighty-four patients were involved in this investigation. Findings revealed that there were a substantial number of delays in initiating post-operative prophylactic biologic therapy in high-risk patients. Results suggested that identifying susceptible patients by insurance type or absence of pre-operative therapy could focus future improvement efforts. In peri-surgical inflammatory bowel disease (IBD) care, consultation with IBD-specialized providers should be considered.